Khaled Daader is the new M&A, IR head at Rameda

Khaled Daader (LinkedIn) has been appointed head of M&A and investor relations at Rameda Pharma effective 1 October, the company said in a press release ( pdf ) Monday. Daader stepped down from his position as head of investor relations at Juhayna on 30 September. He has a background in banking and investor relations from previous roles at the dairy giant and CI Capital. Daader is set to be approved by the board of directors at its next meeting. Juhayna is yet to name his replacement.